The coronary atherectomy devices market consists of sales of coronary atherectomy devices and related services by entities (organizations, sole traders and partnerships) that manufacture coronary atherectomy devices. Coronary atherectomy devices are used to remove atherosclerosis from coronary blood vessels. Only goods and services traded between entities or sold to end consumers are included.
The global coronary atherectomy devices market is expected to decline from $180.11 million in 2019 to $173.32 million in 2020 at a compound annual growth rate (CAGR) of -3.77%. The decline is mainly due to the COVID-19 outbreak that has led to deferred care to avoid visiting hospitals, which resulted in reduced patient volume. The market is then expected to recover and reach $211.85 million in 2023 at a CAGR of 6.92%.
